Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
157 participants
OBSERVATIONAL
2008-12-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data
NCT01161589
Antiarrhythmics Versus Implantable Defibrillators (AVID)
NCT00000531
Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Delays and Its Effects on Mechanical Dyssynchrony
NCT01044784
Arrhythmias Detection in a Real World Population
NCT02275637
Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation
NCT01117792
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has signed the study specific Informed consent document.
* Patient is older than 18 years of age
Exclusion Criteria
* Patient has a documented slow ventricular Tachycardia Episodes previous to the ICD implant.
* Patient not programed with a ventricular Tachycardia (VT) zone upper than 120 bpm.
* Patient requires cardiac resynchronization
* Patient has Brugada Syndrome
* Patient has long QT Syndrome
* Patient has a device replacement;
* Patient is pregnant or nursing
* Patient is unable to attend the follow-up visits
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ignacio Fernández Lozano, PhD.
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario Puerta de Hierro
Javier Alzueta, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Clinico Universitario Virgen de la Victoria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Puerta de Hierro
Madrid, , Spain
Hospital Clínico Universitario Virgen de la Victoria
Málaga, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR08003ES
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.